TABLE 2.
Groups | OVA-specific IgE Levels (EU/ml) | OVA-specific IgG1 Levels (EU/ml) |
---|---|---|
Nonsensitized/OVA/Control | 31.4 ± 11.7 | 18.2 ± 8.1 |
Nonsensitized/OVA/PFD | 26.2 ± 10.4 | 16.7 ± 9.5 |
OVA/OVA/Control | 1046.8 ± 158.9* | 418.0 ± 60.6* |
OVA/OVA/PFD | 582.7 ± 94.0# | 267.2 ± 35.5 |
Definition of abbreviations: OVA, ovalbumin; PFD, pirfenidone.
Significant differences (P < 0.05) between OVA-sensitized/OVA-challenged control mice (receiving saline) (OVA/OVA/Control) and pirfenidone-treated mice (OVA/OVA/PFD). The results for each group are expressed as mean ± SD. n = 16 in each group.
Significant differences (P < 0.05) between nonsensitized/challenged mice (Nonsensitized/OVA/Control) and OVA-sensitized/OVA-challenged mice (OVA/OVA/Control).